US Stock MarketDetailed Quotes

CRISPR Therapeutics (CRSP)

Watchlist
  • 60.810
  • +6.080+11.11%
Close Jan 22 16:00 ET
  • 60.790
  • -0.020-0.03%
Post 20:01 ET
5.80BMarket Cap-10.98P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CRISPR Therapeutics (CRSP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
-90.54%35M
-82.50%35M
0
0
0
84,762.39%370M
3,333,233.33%200M
Operating revenue
--0
--0
--0
-90.54%35M
-82.50%35M
--0
--0
--0
84,762.39%370M
3,333,233.33%200M
Cost of revenue
412.10%57.12M
-13.39%45.15M
22.45%57.51M
-15.36%110.25M
0
-52.38%11.15M
16.79%52.13M
11.31%46.97M
18.14%130.25M
193.13%20M
Gross profit
-412.10%-57.12M
13.39%-45.15M
-22.45%-57.51M
-131.39%-75.25M
-80.56%35M
52.38%-11.15M
-305.53%-52.13M
-181.24%-46.97M
318.32%239.75M
2,740.46%180M
Operating expense
-24.28%74.94M
85.79%184.17M
-2.89%90.92M
-15.35%391.32M
-9.81%99.59M
-9.19%98.98M
-17.79%99.13M
-23.45%93.62M
-17.94%462.29M
-11.47%110.42M
Selling and administrative expenses
-2.80%16.93M
-2.90%18.92M
7.48%19.3M
-4.18%72.98M
9.98%18.12M
-4.77%17.42M
2.36%19.48M
-19.71%17.95M
-25.67%76.16M
-22.16%16.48M
-General and administrative expense
-2.80%16.93M
-2.90%18.92M
7.48%19.3M
-4.18%72.98M
9.98%18.12M
-4.77%17.42M
2.36%19.48M
-19.71%17.95M
-25.67%76.16M
-22.16%16.48M
Research and development costs
-28.31%58.9M
107.26%166.15M
-4.84%72.48M
-17.21%320.65M
-13.65%82.16M
-9.41%82.16M
-21.06%80.17M
-23.78%76.17M
-16.10%387.33M
-8.12%95.14M
Other operating expenses
-47.67%-889K
-72.53%-892K
-71.63%-865K
-91.87%-2.31M
---691K
---602K
---517K
---504K
-58.27%-1.21M
----
Operating profit
-19.91%-132.06M
-51.61%-229.32M
-5.57%-148.42M
-109.66%-466.57M
-192.82%-64.59M
16.83%-110.13M
-58.85%-151.26M
-118.01%-140.59M
66.94%-222.54M
152.90%69.58M
Net non-operating interest income expense
Other net income (expense)
4.68%26.24M
-15.58%22.07M
-45.24%13.54M
44.68%103.9M
39.91%27.98M
21.25%25.06M
42.01%26.14M
94.00%24.72M
216.91%71.82M
74.04%20M
Other non- operating income (expenses)
4.68%26.24M
-15.58%22.07M
-45.24%13.54M
44.68%103.9M
39.91%27.98M
21.25%25.06M
42.01%26.14M
94.00%24.72M
216.91%71.82M
74.04%20M
Income before tax
-24.40%-105.82M
-65.65%-207.26M
-16.42%-134.89M
-140.62%-362.67M
-140.87%-36.61M
23.87%-85.07M
-62.88%-125.12M
-123.92%-115.87M
76.83%-150.72M
174.62%89.58M
Income tax
-29.34%619K
0.39%1.29M
53.18%1.11M
24.20%3.59M
200.43%700K
112.62%876K
39.44%1.29M
-45.15%724K
988.62%2.89M
102.46%233K
Net income
-23.85%-106.44M
-64.98%-208.55M
-16.64%-136M
-138.43%-366.25M
-141.76%-37.31M
23.37%-85.94M
-62.60%-126.41M
-119.71%-116.59M
76.37%-153.61M
180.80%89.35M
Net income continuous Operations
-23.85%-106.44M
-64.98%-208.55M
-16.64%-136M
-138.43%-366.25M
-141.76%-37.31M
23.37%-85.94M
-62.60%-126.41M
-119.71%-116.59M
76.37%-153.61M
180.80%89.35M
Minority interest income
Net income attributable to the parent company
-23.85%-106.44M
-64.98%-208.55M
-16.64%-136M
-138.43%-366.25M
-141.76%-37.31M
23.37%-85.94M
-62.60%-126.41M
-119.71%-116.59M
76.37%-153.61M
180.80%89.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-23.85%-106.44M
-64.98%-208.55M
-16.64%-136M
-138.43%-366.25M
-141.76%-37.31M
23.37%-85.94M
-62.60%-126.41M
-119.71%-116.59M
76.37%-153.61M
180.80%89.35M
Basic earnings per share
-15.84%-1.17
-61.07%-2.4
-10.49%-1.58
-123.71%-4.34
-138.94%-0.44
28.37%-1.01
-52.04%-1.49
-113.43%-1.43
76.79%-1.94
180.14%1.13
Diluted earnings per share
-15.84%-1.17
-61.07%-2.4
-10.49%-1.58
-123.71%-4.34
-138.94%-0.44
28.37%-1.01
-52.04%-1.49
-113.43%-1.43
76.79%-1.94
180.14%1.13
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 000-90.54%35M-82.50%35M00084,762.39%370M3,333,233.33%200M
Operating revenue --0--0--0-90.54%35M-82.50%35M--0--0--084,762.39%370M3,333,233.33%200M
Cost of revenue 412.10%57.12M-13.39%45.15M22.45%57.51M-15.36%110.25M0-52.38%11.15M16.79%52.13M11.31%46.97M18.14%130.25M193.13%20M
Gross profit -412.10%-57.12M13.39%-45.15M-22.45%-57.51M-131.39%-75.25M-80.56%35M52.38%-11.15M-305.53%-52.13M-181.24%-46.97M318.32%239.75M2,740.46%180M
Operating expense -24.28%74.94M85.79%184.17M-2.89%90.92M-15.35%391.32M-9.81%99.59M-9.19%98.98M-17.79%99.13M-23.45%93.62M-17.94%462.29M-11.47%110.42M
Selling and administrative expenses -2.80%16.93M-2.90%18.92M7.48%19.3M-4.18%72.98M9.98%18.12M-4.77%17.42M2.36%19.48M-19.71%17.95M-25.67%76.16M-22.16%16.48M
-General and administrative expense -2.80%16.93M-2.90%18.92M7.48%19.3M-4.18%72.98M9.98%18.12M-4.77%17.42M2.36%19.48M-19.71%17.95M-25.67%76.16M-22.16%16.48M
Research and development costs -28.31%58.9M107.26%166.15M-4.84%72.48M-17.21%320.65M-13.65%82.16M-9.41%82.16M-21.06%80.17M-23.78%76.17M-16.10%387.33M-8.12%95.14M
Other operating expenses -47.67%-889K-72.53%-892K-71.63%-865K-91.87%-2.31M---691K---602K---517K---504K-58.27%-1.21M----
Operating profit -19.91%-132.06M-51.61%-229.32M-5.57%-148.42M-109.66%-466.57M-192.82%-64.59M16.83%-110.13M-58.85%-151.26M-118.01%-140.59M66.94%-222.54M152.90%69.58M
Net non-operating interest income expense
Other net income (expense) 4.68%26.24M-15.58%22.07M-45.24%13.54M44.68%103.9M39.91%27.98M21.25%25.06M42.01%26.14M94.00%24.72M216.91%71.82M74.04%20M
Other non- operating income (expenses) 4.68%26.24M-15.58%22.07M-45.24%13.54M44.68%103.9M39.91%27.98M21.25%25.06M42.01%26.14M94.00%24.72M216.91%71.82M74.04%20M
Income before tax -24.40%-105.82M-65.65%-207.26M-16.42%-134.89M-140.62%-362.67M-140.87%-36.61M23.87%-85.07M-62.88%-125.12M-123.92%-115.87M76.83%-150.72M174.62%89.58M
Income tax -29.34%619K0.39%1.29M53.18%1.11M24.20%3.59M200.43%700K112.62%876K39.44%1.29M-45.15%724K988.62%2.89M102.46%233K
Net income -23.85%-106.44M-64.98%-208.55M-16.64%-136M-138.43%-366.25M-141.76%-37.31M23.37%-85.94M-62.60%-126.41M-119.71%-116.59M76.37%-153.61M180.80%89.35M
Net income continuous Operations -23.85%-106.44M-64.98%-208.55M-16.64%-136M-138.43%-366.25M-141.76%-37.31M23.37%-85.94M-62.60%-126.41M-119.71%-116.59M76.37%-153.61M180.80%89.35M
Minority interest income
Net income attributable to the parent company -23.85%-106.44M-64.98%-208.55M-16.64%-136M-138.43%-366.25M-141.76%-37.31M23.37%-85.94M-62.60%-126.41M-119.71%-116.59M76.37%-153.61M180.80%89.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -23.85%-106.44M-64.98%-208.55M-16.64%-136M-138.43%-366.25M-141.76%-37.31M23.37%-85.94M-62.60%-126.41M-119.71%-116.59M76.37%-153.61M180.80%89.35M
Basic earnings per share -15.84%-1.17-61.07%-2.4-10.49%-1.58-123.71%-4.34-138.94%-0.4428.37%-1.01-52.04%-1.49-113.43%-1.4376.79%-1.94180.14%1.13
Diluted earnings per share -15.84%-1.17-61.07%-2.4-10.49%-1.58-123.71%-4.34-138.94%-0.4428.37%-1.01-52.04%-1.49-113.43%-1.4376.79%-1.94180.14%1.13
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -